To the Editor: Dr De Jonghe and colleagues1 concluded that "there was an important role of
corticosteroids in the development of ICUAP" and recommended that corticosteroid
administration be limited to patients who have indications based on evidence-based
indications. Although we agree that corticosteroids, like any other intervention,
should be limited to patients who have a proven benefit, it is difficult to
find a causal relationship between paresis and corticosteroid use in their
study. The control and case patients received corticosteroids for a similar
number of days, and the control group actually received a higher total dose
of corticosteroids.